综合一区欧美国产,99国产麻豆免费精品,九九精品黄色录像,亚洲激情青青草,久久亚洲熟妇熟,中文字幕av在线播放,国产一区二区卡,九九久久国产精品,久久精品视频免费

USEUROPEAFRICAASIA 中文雙語Fran?ais
Lifestyle
Home / Lifestyle / News

Shortage of life-saving heart drug

By Zhou Wenting | China Daily | Updated: 2011-09-13 11:11

BEIJING - Experts have called for a national drug-control system after a nationwide deficit of a life-saving drug, which has lasted at least three months.

Doctors at a Beijing hospital said some specialized hospitals, which perform hundreds of cardiac operations every month, have been paralyzed by their lack of protamine sulfate, which is commonly administered after heart surgery to reverse the anticoagulant effects of heparin.

The earliest report of a shortage was in Hubei province on July 21. This was followed by reports of shortages in Guangdong, Shandong and Liaoning provinces.

The Shandong newspaper, Qilu Evening News, quoted a regional sales manager, surnamed Zhuang, as saying the province had been allocated 150 doses of protamine sulfate after Shanghai No 1 Biochemical and Pharmaceutical Co Ltd recently resumed production of the drug.

"But its monthly use here is usually 10,000 doses," he said.

The Ministry of Health has denied it is responsible for supplies of the drug and passed the buck to the State Food and Drug Administration, claiming the latter is responsible for the supervision of medicines.

Shen Chen, head of the publicity office of the State Food and Drug Administration, said he was unaware of the shortage, but said the administration is responsible for the quality of medicines, not the supply.

"Development and reform authorities oversee the medicines' prices, while the industrial and commercial authorities oversee the storage. The food and drug departments only cover the approval and quality of medicines."

Industry insiders said one of the reasons for the shortage was the low profit margin, which discourages companies from mass producing the drug.

"Some companies can't earn enough to recover their costs, therefore it is almost impossible to maintain their enthusiasm for continuing production," said Lu Guoping, secretary-general of the Shanghai Pharmaceutical Trade Association.

Lu said the government should issue policies to prevent future shortages of such medicines to avoid possible nationwide public health incidents.

Yi Shenghua, a lawyer at Beijing Yingke Law Firm, said the country should have a unified system to guarantee the normal supply of medicines that are widely used and drug manufacturers should fulfill their responsibilities to society, even though there is no law stipulating they should produce specific medicines.

He came up with two ways to deal with the problem of companies only producing profitable drugs.

"The government can order businesses to manufacture a certain amount of cheap medicines. Or it can offer financial assistance to subsidize cheap, but life-saving medicines."

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
蚌埠市| 金平| 买车| 砀山县| 宁陵县| 缙云县| 金秀| 阳信县| 武隆县| 广河县| 洞头县| 安平县| 阿瓦提县| 金塔县| 临沧市| 洞口县| 丰县| 大石桥市| 隆回县| 柯坪县| 永修县| 名山县| 连平县| 无棣县| 洛扎县| 宁蒗| 郯城县| 安康市| 崇明县| 炎陵县| 甘肃省| 汉中市| 巴彦县| 荥阳市| 汶上县| 定襄县| 兴安县| 喀喇| 霍山县| 龙里县| 永丰县|